Authors
Latest:
Evaluating Technology and Innovation in Biopharmaceutical ManufacturingA technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.
Latest:
Evaluating Technology and Innovation in Biopharmaceutical ManufacturingA technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.
Latest:
Evaluating Technology and Innovation in Biopharmaceutical ManufacturingA technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.
Latest:
Evaluating Technology and Innovation in Biopharmaceutical ManufacturingA technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.
Latest:
Evaluating Technology and Innovation in Biopharmaceutical ManufacturingA technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.
Latest:
Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition TemperatureAn approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Latest:
Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition TemperatureAn approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Latest:
Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition TemperatureAn approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Latest:
The Flexibility of Small-Scale Single-Use Bioreactor SolutionsThe authors present a case study in which four single-use vessels were fitted to an existing bioreactor system.
Latest:
The Flexibility of Small-Scale Single-Use Bioreactor SolutionsThe authors present a case study in which four single-use vessels were fitted to an existing bioreactor system.
Latest:
The Flexibility of Small-Scale Single-Use Bioreactor SolutionsThe authors present a case study in which four single-use vessels were fitted to an existing bioreactor system.
Latest:
Safe Freeze–Thaw of Protein Drug Products: A QbD ApproachApply a DoE strategy to test several formulations in parallel.
Latest:
Safety Drives Innovation in Animal-Component-Free Cell-Culture Media TechnologyAdvances in cell culture media technology have helped achieve safer biologics.
Latest:
Development of a Technique for Quantifying Protein DegradationThis article demonstrates that a modified SDS–PAGE can be easily used as a tool for quantifying the degree of protein degradation.
Latest:
Optimizing Diaphragm Valves to Improve Bioprocess ReliabilityValve design and materials affect performance and cost to maintain.
Latest:
Implementing a Dual Approach to Protein CharacterizationInnovations in electrophoresis and chromatography upstream of protein characterization can accelerate research.
Latest:
Implementing a Dual Approach to Protein CharacterizationInnovations in electrophoresis and chromatography upstream of protein characterization can accelerate research.
Latest:
Biomanufacturing: Demand for Continuous Bioprocessing IncreasingBut are innovations sufficient to increase adoption? CMOs are demanding better continuous bioprocessing options.
Latest:
Top Trends in Biopharmaceutical Manufacturing, 2017Innovation speeds discovery, drives down costs, and improves productivity.
Latest:
HPLE Sugars Improve Stability and Drug ProductHigh-purity low-endotoxin sugars improve robustness and stability of protein formulation and improve drug product quality.
Latest:
Antibody Drug Conjugate Purification Using TOYOPEARL® PPG-600M ResinIn this application note, antibody drug conjugates (ADCs) were separated into groups with low, medium, and high drug-to-antibody ratios (DARs) using TOYOPEARL PPG-600M resin with a three-step gradient.
Latest:
Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition TemperatureAn approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Latest:
Virus Risk Mitigation in Cell Culture MediaA new virus-retentive membrane may be used to filter chemical-defined cell culture media for risk mitigation.
Latest:
Virus Risk Mitigation in Cell Culture MediaA new virus-retentive membrane may be used to filter chemical-defined cell culture media for risk mitigation.
